SlideShare a Scribd company logo
1 of 52
Download to read offline
Neoplasm
● The term neoplasm refers to an abnormal
growth of tissue caused by the rapid division of
cells that have undergone some form of
mutation.
● Greek words "neo" meaning new and "plasma"
meaning formation.
● Tumor: a swelling of a part of the body,
generally without inflammation, caused by an
abnormal growth of tissue, whether benign or
malignant.
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
Types of Neoplasm
WHO classifies neoplasms into four main groups:
1. Benign neoplasm:
Benign (non-cancerous) tumor is a mass of cells (tumor) that lacks the ability to
invade neighboring tissue or metastasize. They are circumscribed and
localized and do not transform into cancer. These neoplasms do not become
cancerous and are not usually life threatening, but depending on its location, a
benign growth may cause symptoms and signs if it presses on vital neighboring
structures such as glands or nerves.
E.g. Adenomas - Adenoma is a benign tumor of glandular tissue, such as the
mucosa of stomach, small intestine, and colon, in which tumor cells form glands
or gland like structures.
Skin moles - Moles occur when cells in the skin grow in a cluster instead of
being spread throughout the skin.
Fibromas - These are growths that arise in the connective or fibrous tissue.
Hemangiomas - A birthmark often appearing as a rubbery, bright red nodule of
extra blood vessels.
Lipomas - A fatty lump most often situated between the skin and underlying
muscle layer.
Osteoma, Papilloma, Meningioma, Lymphangioma, Chondroma,
Astrocytoma etc.
Adenomas
skin molesHemangiomas Lipomas
Uterine fibroidsOsteoma
2. Malignant neoplasms (Cancer)
They invade and destroy the surrounding tissue, may form metastases and, if
untreated or unresponsive to treatment, will prove fatal.
e.g.
Carcinoma - This cancer begins in the skin or tissues that line internal organs.
Leukemia - This form affects tissues that make blood, such as the bone
marrow. Large numbers of abnormal cells are produced in the bone marrow
which then enter the bloodstream.
Lymphoma - This refers to cancer that originates in the immune system.
- Hodgkin's lymphoma and non-Hodgkin's lymphoma
Sarcoma - This develops in bone fat, muscle, blood vessels, cartilage, bone or
other types of connective tissue.
Cancer of the central nervous system - This form of cancer originates in the
tissues of the spinal cord and brain.
Melanoma – Skin cancer
Cancers related to Bladder, Breast, Brain, Liver, Cervical, Colorectal,
Kidney, Lung, Ovarian, Pancreatic, Prostate, Thyroid, Uterine Cancers
Carcinoma Leukemia
SarcomaLymphoma
Brain tumor
Melanoma
Neoplasm icd 10 guideline
3. Malignant neoplasm Secondary:
Refers to any of a class of cancerous tumor that is either a metastatic
offshoot of a primary tumor, or an apparently unrelated tumor that
increases in frequency following certain cancer treatments such as
chemotherapy or radiotherapy
4. Cancer in situ (In the original place):
An early stage cancer in which the cancerous growth or tumor is still
confined to the site from which it started, and has not spread to
surrounding tissue or other organs in the body. They are localised, do
not invade and destroy but in time, may transform into a cancer.
5. Uncertain behavior:
The term "neoplasm of uncertain behavior" is a specific pathologic
diagnosis. This is a lesion whose behavior cannot be predicted. It's
currently benign, but there's a chance that it could undergo malignant
transformation over time.
Lesion - a region in an organ or tissue which has suffered damage
through injury or disease, such as a wound, ulcer, abscess, or tumour.
Lesion
What Causes Cancer
 Genetics
 Tobacco
 Diet and Physical Activity
Being overweight or obese
 Alcohol : Mouth, throat, voice box, esophagus, Liver, Colon, Breast.
 Sun and UV Exposure
 Radiation Exposure: X-rays, Gamma Rays, Radon, Second cancer
caused by cancer treatment, Microwaves, Radio Waves, and Other
Types of Radiofrequency Radiation, Cellular phones, Mobile towers,
Electrical devices, Power lines.
 Other Carcinogens : lead, arsenic, cosmetics, hair dyes, asbestos,
benzene, or formaldehyde, pollution,
Types of Treatment
There are many types of cancer treatment. The types of treatment that you
receive will depend on the type of cancer you have and how advanced it is.
The main types of cancer treatment include:
1. Surgery
Surgery is a procedure in which a surgeon removes cancer from your
body.
2. Radiation Therapy
Radiation therapy (also called radiotherapy) is a cancer treatment that
uses high doses of radiation to kill cancer cells and shrink tumors. At
low doses, radiation is used in x-rays to see inside your body, as with x-
rays of your teeth or broken bones.
3. Chemotherapy
Chemotherapy (also called chemo) is a type of cancer treatment that
uses drugs to kill cancer cells. They are one of the most toxic drugs
used in therapy.
Side effects: Immunosuppression, Typhlitis, Gastrointestinal distress,
Anemia, Fatigue, Nausea and vomiting, Hair loss, Secondary neoplasm,
Infertility, Teratogenicity, Peripheral neuropathy, Cognitive
impairment, Tumor lysis syndrome, Organ damage, Other side-effects.
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
Neoplasm icd 10 guideline
4. Immunotherapy
Immunotherapy is a type of cancer treatment that helps your immune
system fight cancer. It is made up of white blood cells and organs and
tissues of the lymph system.
e.g. Monoclonal antibodies, Cytokines, Vaccines, BCG (Bacillus
Calmette-Guérin)
5. Targeted Therapy
6. Hormone Therapy
7. Stem Cell Transplant
8. Precision Medicine
ICD-10-CM Official Guidelines for
Coding and Reporting
FY 2017
General guidelines
• Chapter 2 of the ICD-10-CM contains the codes for
most benign and all malignant neoplasms.
• To properly code a neoplasm it is necessary to
determine from the record if the neoplasm is benign,
in-situ, malignant, or of uncertain histologic behaviour.
If malignant, any secondary (metastatic) sites should
also be determined.
Chapter 2: Neoplasms (C00-D49)
• The neoplasm table in the Alphabetic Index should be referenced first.
• However, if the histological term is documented, that term should be
referenced first, rather than going immediately to the Neoplasm Table,
in order to determine which column in the Neoplasm Table is
appropriate.
• For example, if the documentation indicates “adenoma,” refer to the
term in the Alphabetic Index to review the entries under this term and
the instructional note to “see also neoplasm, by site, benign.”
• The table provides the proper code based on the type of neoplasm and
the site.
 Primary malignant neoplasms overlapping site boundaries
• A primary malignant neoplasm that overlaps two or more
contiguous (next to each other) sites should be classified to the
subcategory/code -.8 ('overlapping lesion'), unless the
combination is specifically indexed elsewhere.
E.g. C00.8 - Malignant neoplasm of overlapping sites of lip.
C10.8 - Malignant neoplasm of overlapping sites of oropharynx
• For multiple neoplasms of the same site that are not contiguous
such as tumors in different quadrants of the same breast, codes
for each site should be assigned.
 Malignant neoplasm of ectopic tissue (In an abnormal place
or position): Malignant neoplasms of ectopic tissue are to
be coded to the site of origin mentioned, e.g., ectopic
pancreatic malignant neoplasms involving the stomach are
coded to pancreas, unspecified (C25.9).
a) Treatment directed at the malignancy
If the treatment is directed at the malignancy, designate the
malignancy as the principal diagnosis.
The only exception to this guideline is if a patient
admission/encounter is solely for the administration of
chemotherapy, immunotherapy or radiation therapy, assign the
appropriate Z51.-- code as the first-listed or principal diagnosis, and
the diagnosis or problem for which the service is being performed as a
secondary diagnosis.
b. Treatment of secondary site
When a patient is admitted because of a primary neoplasm with
metastasis and treatment is directed toward the secondary site only,
the secondary neoplasm is designated as the principal diagnosis even
though the primary malignancy is still present.
C) Coding and sequencing of complications
1. Anemia associated with malignancy
Principal Dx will be malignancy followed by anemia code (i.e. D63.0,
Anemia in neoplastic Disease).
2. Anemia associated with chemotherapy and immunotherapy
Principal Dx will be anemia code followed by the appropriate codes for
the neoplasm and the adverse effect (T45.1X5, Adverse effect of
antineoplastic and immunosuppressive drugs).
3. Anemia associated with radiation therapy
Principal Dx will be anemia code followed by the appropriate neoplasm
code and code Y84.2, Radiological procedure and radiotherapy as the
cause of abnormal reaction of the patient, or of later complication,
without mention of misadventure at the time of the procedure.
4. Management of dehydration due to the malignancy
If dehydration is being treated (intravenous rehydration), the
dehydration is sequenced first, followed by the code(s) for the
malignancy.
5. Treatment of a complication resulting from a surgical procedure
Complication as the principal or first-listed diagnosis if treatment is
directed at resolving the complication.
d) Primary malignancy previously excised
When a primary malignancy has been previously excised or eradicated
from its site and there is no further treatment directed to that site and
there is no evidence of any existing primary malignancy, a code from
category Z85, Personal history of malignant neoplasm, should be used
to indicate the former site of the malignancy. Any mention of extension,
invasion, or metastasis to another site is coded as a secondary
malignant neoplasm to that site. The secondary site may be the
principal or first-listed with the Z85 code used as a secondary code.
e) Admissions/Encounters involving chemotherapy, immunotherapy
and radiation therapy
1. Episode of care involves surgical removal of neoplasm
When an episode of care involves the surgical removal of a neoplasm,
primary or secondary site, followed by adjunct chemotherapy or
radiation treatment during the same episode of care, the code for the
neoplasm should be assigned as principal or first-listed diagnosis.
2. Patient admission/encounter solely for administration of
chemotherapy, immunotherapy and radiation therapy
Assign the appropriate Z51.-- code as the first-listed or principal
diagnosis, If a patient receives more than one of these therapies during
the same admission more than one of these codes may be assigned, in
any sequence. The malignancy for which the therapy is being
administered should be assigned as a secondary diagnosis.
3. Patient admitted for radiation therapy, chemotherapy or
immunotherapy and develops complications
Assign the appropriate Z51.-- code as the first-listed or principal
diagnosis, followed by any codes for the complications such as
uncontrolled nausea and vomiting or dehydration.
f. Admission/encounter to determine extent of malignancy
When the reason for admission/encounter is to determine the extent
of the malignancy, or for a procedure such as paracentesis or
thoracentesis, the primary malignancy or appropriate metastatic
site is designated as the principal or first-listed diagnosis, even
though chemotherapy or radiotherapy is administered.
g. Symptoms, signs, and abnormal findings listed in Chapter 18
associated with neoplasms
Symptoms, signs, and ill-defined conditions listed in Chapter 18
characteristic of, or associated with, an existing primary or secondary
site malignancy cannot be used to replace the malignancy as principal
or first-listed diagnosis, regardless of the number of admissions or
encounters for treatment and care of the neoplasm.
h. Admission/encounter for pain control/management
See Section I.C.6. for information on coding admission/encounter for
pain control/management.
Neoplasm Related Pain
Code G89.3 is assigned to pain documented as being related,
associated or due to cancer, primary or secondary malignancy, or
tumor. This code is assigned regardless of whether the pain is acute or
chronic. This code may be assigned as the principal or first-listed
code when the stated reason for the admission/encounter is
documented as pain control/pain management. The underlying
neoplasm should be reported as an additional diagnosis. When the
reason for the admission/encounter is management of the
neoplasm and the pain associated with the neoplasm is also
documented, code G89.3 may be assigned as an additional diagnosis.
It is not necessary to assign an additional code for the site of the pain.
i. Malignancy in two or more noncontiguous sites
A patient may have more than one malignant tumor in the same organ.
These tumors may represent different primaries or metastatic disease,
depending on the site. If the documentation be unclear, then the
provider should be queried as to the status of each tumor so that
the correct codes can be assigned.
j. Disseminated malignant neoplasm, unspecified (spread throughout
an organ or the body)
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use
only in those cases where the patient has advanced metastatic
disease and no known primary or secondary sites are specified. It
should not be used in place of assigning codes for the primary site
and all known secondary sites.
k. Malignant neoplasm without specification of site
Code C80.1, Malignant (primary) neoplasm, unspecified, equates to
Cancer, unspecified. This code should only be used when no
determination can be made as to the primary site of a malignancy. This
code should rarely be used in the inpatient setting.
l. Sequencing of neoplasm codes
1) Encounter for treatment of primary malignancy
If the reason for the encounter is for treatment of a primary malignancy,
assign the malignancy as the principal/first-listed diagnosis. The primary
site is to be sequenced first, followed by any metastatic sites.
2) Encounter for treatment of secondary malignancy
When an encounter is for a primary malignancy with metastasis and
treatment is directed toward the metastatic (secondary) site(s) only, the
metastatic site(s) is designated as the principal/first-listed diagnosis. The
primary malignancy is coded as an additional code.
3) Malignant neoplasm in a pregnant patient
When a pregnant woman has a malignant neoplasm, a code from subcategory
O9A.1-, Malignant neoplasm complicating pregnancy, childbirth, and the
puerperium, should be sequenced first, followed by the appropriate code
from Chapter 2 to indicate the type of neoplasm.
4) Encounter for complication associated with a neoplasm
When an encounter is for management of a complication associated
with a neoplasm, such as dehydration, and the treatment is only for
the complication, the complication is coded first, followed by the
appropriate code(s) for the neoplasm. The exception to this guideline
is anemia. When the admission/encounter is for management of an
anemia associated with the malignancy, and the treatment is only for
anemia, the appropriate code for the malignancy is sequenced as the
principal or first-listed diagnosis followed by code D63.0, Anemia in
neoplastic disease.
5) Complication from surgical procedure for treatment of a neoplasm
When an encounter is for treatment of a complication resulting from a
surgical procedure performed for the treatment of the neoplasm,
designate the complication as the principal/first-listed diagnosis.
See guideline regarding the coding of a current malignancy versus
personal history to determine if the code for the neoplasm should also
be assigned.
6) Pathologic fracture due to a neoplasm
When an encounter is for a pathological fracture due to a neoplasm,
and the focus of treatment is the fracture, a code from subcategory
M84.5, Pathological fracture in neoplastic disease, should be
sequenced first, followed by the code for the neoplasm. If the focus
of treatment is the neoplasm with an associated pathological
fracture, the neoplasm code should be sequenced first, followed by a
code from M84.5 for the pathological fracture.
m. Current malignancy versus personal history of
malignancy
When a primary malignancy has been excised but further
treatment, such as an additional surgery for the malignancy,
radiation therapy or chemotherapy is directed to that site, the
primary malignancy code should be used until treatment is
completed. When a primary malignancy has been previously
excised or eradicated from its site, there is no further treatment
(of the malignancy) directed to that site, and there is no
evidence of any existing primary malignancy, a code from
category Z85, Personal history of malignant neoplasm, should
be used to indicate the former site of the malignancy.
• Z80 Family history of primary malignant neoplasm
• Z85 Personal history of malignant neoplasm
n. Leukemia, Multiple Myeloma, and Malignant Plasma Cell
Neoplasms in remission versus personal history
The categories for leukemia, and category C90, Multiple myeloma and
malignant plasma cell neoplasms, have codes indicating whether or
not the leukemia has achieved remission. There are also codes Z85.6,
Personal history of leukemia, and Z85.79, Personal history of other
malignant neoplasms of lymphoid, hematopoietic and related tissues.
If the documentation is unclear as to whether the leukemia has
achieved remission, the provider should be queried.
o. Aftercare following surgery for neoplasm
Z51.-- Encounter for other aftercare and medical care
p. Follow-up care for completed treatment of a malignancy
Z08 Encounter for follow-up examination after completed treatment
for malignant neoplasm.
The follow-up codes are used to explain continuing surveillance
following completed treatment of a disease, condition, or injury. They
imply that the condition has been fully treated and no longer exists.
They should not be confused with aftercare codes, or injury codes
with a 7th character for subsequent encounter, that explain ongoing
care of a healing condition or its sequelae. Follow-up codes may
be used in conjunction with history codes to provide the full picture
of the healed condition and its treatment. The follow-up code is
sequenced first, followed by the history code. A follow-up code may
be used to explain multiple visits. Should a condition be found to have
recurred on the follow-up visit, then the diagnosis code for the
condition should be assigned in place of the follow-up code.
q. Prophylactic organ removal for prevention of malignancy
Prophylactic Organ Removal
For encounters specifically for prophylactic removal of an organ (such
as prophylactic removal of breasts due to a genetic susceptibility to
cancer or a family history of cancer), the principal or first-listed code
should be a code from category Z40, Encounter for prophylactic
surgery, followed by the appropriate codes to identify the
associated risk factor (such as genetic susceptibility or family
history). If the patient has a malignancy of one site and is having
prophylactic removal at another site to prevent either a new primary
malignancy or metastatic disease, a code for the malignancy should
also be assigned in addition to a code from subcategory Z40.0,
Encounter for prophylactic surgery for risk factors related to
malignant neoplasms. A Z40.0 code should not be assigned if the
patient is having organ removal for treatment of a malignancy, such as
the removal of the testes for the treatment of prostate cancer.
r. Malignant neoplasm associated with transplanted organ
A malignant neoplasm of a transplanted organ should be coded as a
transplant complication. Assign first the appropriate code from
category T86.-, Complications of transplanted organs and tissue,
followed by code C80.2, Malignant neoplasm associated with
transplanted organ. Use and additional code for the specific
malignancy.
CODING EXAMPLES FOR NEOPLASM
1. A 50 years old female was diagnosed with left breast carcinoma four years
ago, at that time she had a left mastectomy performed with chemotherapy
administration. She has been well since that time with no further treatment;
except for yearly checkups. The patient is now being seen with visual
disturbances, dizziness, headaches and blurred vision. Workup was
completed which confirmed metastasis to the brain, accounting for these
symptoms. This was identified as being metastatic from the breast, not a new
primary.
What will be the diagnosis codes ?
Answer:
C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary site
Z85.3 - History, personal (of), malignant neoplasm (of), breast
Z90.12 - Absence (of) (organ or part) (complete or partial), breast(s) (and
nipple(s)) (acquired)
Z92.21 - History, personal (of)chemotherapy for neoplastic condition
2. The diagnosis for a 61 years old female patient is small cell
carcinoma of the right lower lobe of the lung with metastasis
to the intrathoracic lymph nodes, brain and right rib.
What will be the diagnosis codes ?
Answer:
C34.31 – Carcinoma, see also Neoplasm, by site, malignant. Refer to
Neoplasm Table, by site (lung), malignant, primary site, lower lobe
C77.1 - Refer to Neoplasm Table, by site, lymph gland, malignant,
intrathoracic, secondary site
C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary
site
C79.51 - Refer to Neoplasm Table, by site, bone, malignant, rib, secondary
site
3. The encounter is to receive chemotherapy following the recent
diagnosis of carcinoma of the small intestines. The tumor
was in the area where the duodenum and jejunum join. The
cancer was resected two months ago and the patient has
been receiving chemotherapy.
What will be the diagnosis codes ?
Answer:
Z51.11 - Chemotherapy (session) (for), cancer
C17.8 – Carcinoma, see also Neoplasm, by site, malignant. Refer to
Neoplasm Table, by site, intestine, small,overlapping lesion,
malignant, primary site
Z90.49 - Absence (of) (organ or part) (complete or partial), intestine
(acquired) (small)
4. Female patient with terminal carcinoma of the central portion of
the right breast, metastatic to the liver and brain, was seen
for dehydration and chronic intractable neoplasm related
pain. Patient was rehydrated with IVs and given IV pain
medication with no treatment directed toward the cancer.
What will be the diagnosis codes ?
Answer:
E86.0 - Dehydration
G89.3 – Pain(s) (see also Painful), chronic, neoplasm related
C50.111 – Carcinoma, see also Neoplasm, by site, malignant. Refer to
Neoplasm Table, by site (breast), malignant, primary site, central
portion
C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary
site
C78.7 - Refer to Neoplasm Table, by site, liver, malignant, secondary
site
5. A 25 years old female is treated for melanoma of the breast and left
arm.
What will be the diagnosis codes ?
Answer:
C43.52 - Melanoma (malignant), skin, breast (female) (male)
C43.62 - Melanoma (malignant), skin, arm. Review the Tabular for
complete code assignment.
Neoplasm icd 10 guideline

More Related Content

What's hot

Documentation and coding for icd 10
Documentation and coding for icd 10Documentation and coding for icd 10
Documentation and coding for icd 10MVNPA
 
Injury,poisoning and certain other consequences of external causes
Injury,poisoning and certain other consequences of external causesInjury,poisoning and certain other consequences of external causes
Injury,poisoning and certain other consequences of external causesMedesun Healthcare Solutions LLC
 
E&M
E&ME&M
E&Myury
 
HCC CODING training manual
HCC CODING training manualHCC CODING training manual
HCC CODING training manualAlan Smith
 
ICD-10 Presentation Takes Coding to New Heights
ICD-10 Presentation Takes Coding to New HeightsICD-10 Presentation Takes Coding to New Heights
ICD-10 Presentation Takes Coding to New HeightsPYA, P.C.
 
CPT and HCPCS Coding
CPT and HCPCS CodingCPT and HCPCS Coding
CPT and HCPCS CodingRay Arons
 
ICD-10 Overview
ICD-10 OverviewICD-10 Overview
ICD-10 OverviewPATHS LLC
 
Clinical Documentation Guidelines for ICD-10-CM
Clinical Documentation Guidelines for ICD-10-CMClinical Documentation Guidelines for ICD-10-CM
Clinical Documentation Guidelines for ICD-10-CMPamela Marasco
 
Chapter 20 ICD-10-CM Coding Guidelines 2019
Chapter 20 ICD-10-CM Coding Guidelines 2019Chapter 20 ICD-10-CM Coding Guidelines 2019
Chapter 20 ICD-10-CM Coding Guidelines 2019Paula Akialis
 
Medical coding - introduction
Medical coding - introductionMedical coding - introduction
Medical coding - introductionIndira Kandasamy
 

What's hot (20)

Documentation and coding for icd 10
Documentation and coding for icd 10Documentation and coding for icd 10
Documentation and coding for icd 10
 
Medical Coding Training Online Minicourse
Medical Coding Training Online MinicourseMedical Coding Training Online Minicourse
Medical Coding Training Online Minicourse
 
Radilogy
RadilogyRadilogy
Radilogy
 
Modifiers-CPT CODING
Modifiers-CPT CODINGModifiers-CPT CODING
Modifiers-CPT CODING
 
EVALUATION AND MANAGEMENT CPT CODING-2017
EVALUATION AND MANAGEMENT CPT CODING-2017EVALUATION AND MANAGEMENT CPT CODING-2017
EVALUATION AND MANAGEMENT CPT CODING-2017
 
Injury,poisoning and certain other consequences of external causes
Injury,poisoning and certain other consequences of external causesInjury,poisoning and certain other consequences of external causes
Injury,poisoning and certain other consequences of external causes
 
ICD-10-CM - An Introduction
ICD-10-CM - An IntroductionICD-10-CM - An Introduction
ICD-10-CM - An Introduction
 
E&M
E&ME&M
E&M
 
HCC CODING training manual
HCC CODING training manualHCC CODING training manual
HCC CODING training manual
 
ICD-10 Presentation Takes Coding to New Heights
ICD-10 Presentation Takes Coding to New HeightsICD-10 Presentation Takes Coding to New Heights
ICD-10 Presentation Takes Coding to New Heights
 
CPT and HCPCS Coding
CPT and HCPCS CodingCPT and HCPCS Coding
CPT and HCPCS Coding
 
Anesthesia CPT Coding 2017
Anesthesia CPT Coding 2017Anesthesia CPT Coding 2017
Anesthesia CPT Coding 2017
 
MEDICAL CODING
MEDICAL CODINGMEDICAL CODING
MEDICAL CODING
 
ICD-10 Overview
ICD-10 OverviewICD-10 Overview
ICD-10 Overview
 
External causes of morbidity
External causes  of morbidityExternal causes  of morbidity
External causes of morbidity
 
Clinical Documentation Guidelines for ICD-10-CM
Clinical Documentation Guidelines for ICD-10-CMClinical Documentation Guidelines for ICD-10-CM
Clinical Documentation Guidelines for ICD-10-CM
 
Chapter 20 ICD-10-CM Coding Guidelines 2019
Chapter 20 ICD-10-CM Coding Guidelines 2019Chapter 20 ICD-10-CM Coding Guidelines 2019
Chapter 20 ICD-10-CM Coding Guidelines 2019
 
Icd presentation
Icd presentationIcd presentation
Icd presentation
 
Medicaid Presentation
Medicaid PresentationMedicaid Presentation
Medicaid Presentation
 
Medical coding - introduction
Medical coding - introductionMedical coding - introduction
Medical coding - introduction
 

Viewers also liked

Pathology neoplasm
Pathology  neoplasmPathology  neoplasm
Pathology neoplasmMBBS IMS MSU
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's pathPrasad CSBR
 
General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsviancksislove
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerSubramani Parasuraman
 
Fracture Coding CM and PCS
Fracture Coding CM and PCSFracture Coding CM and PCS
Fracture Coding CM and PCSChar Gore
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer ScreeningClinton Pong
 
CLASSIFICATION OF TUMOURS
CLASSIFICATION OF TUMOURSCLASSIFICATION OF TUMOURS
CLASSIFICATION OF TUMOURSelkablawy
 
Pathology lab neoplasia 2
Pathology lab   neoplasia 2Pathology lab   neoplasia 2
Pathology lab neoplasia 2MBBS IMS MSU
 
Icd10 Presentation
Icd10 PresentationIcd10 Presentation
Icd10 Presentationblabar
 
Staining by hematoxylin and eosin
Staining by hematoxylin and eosinStaining by hematoxylin and eosin
Staining by hematoxylin and eosinSowmya Srinivas
 
hematoxylin and eosin stains
hematoxylin and eosin stainshematoxylin and eosin stains
hematoxylin and eosin stainsUpama Sishan
 
Hematoxylin & eosinstaining
Hematoxylin & eosinstainingHematoxylin & eosinstaining
Hematoxylin & eosinstainingLayal Fahad
 
[Gen. surg] neoplasm (tumor) from SIMS Lahore
[Gen. surg] neoplasm (tumor) from SIMS Lahore[Gen. surg] neoplasm (tumor) from SIMS Lahore
[Gen. surg] neoplasm (tumor) from SIMS LahoreMuhammad Ahmad
 
Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)BioGenex
 
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACFINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACK BHATTACHARJEE
 

Viewers also liked (20)

Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
 
Pathology neoplasm
Pathology  neoplasmPathology  neoplasm
Pathology neoplasm
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's path
 
General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasms
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancer
 
Fracture Coding CM and PCS
Fracture Coding CM and PCSFracture Coding CM and PCS
Fracture Coding CM and PCS
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screening
 
CLASSIFICATION OF TUMOURS
CLASSIFICATION OF TUMOURSCLASSIFICATION OF TUMOURS
CLASSIFICATION OF TUMOURS
 
Pathology lab neoplasia 2
Pathology lab   neoplasia 2Pathology lab   neoplasia 2
Pathology lab neoplasia 2
 
Parotid Neoplasm
Parotid NeoplasmParotid Neoplasm
Parotid Neoplasm
 
NEOPLASM
NEOPLASMNEOPLASM
NEOPLASM
 
Icd10 Presentation
Icd10 PresentationIcd10 Presentation
Icd10 Presentation
 
Staining by hematoxylin and eosin
Staining by hematoxylin and eosinStaining by hematoxylin and eosin
Staining by hematoxylin and eosin
 
hematoxylin and eosin stains
hematoxylin and eosin stainshematoxylin and eosin stains
hematoxylin and eosin stains
 
Hematoxylin & eosinstaining
Hematoxylin & eosinstainingHematoxylin & eosinstaining
Hematoxylin & eosinstaining
 
Oral Biopsy
Oral BiopsyOral Biopsy
Oral Biopsy
 
H & E staining part 1
H & E staining part 1H & E staining part 1
H & E staining part 1
 
[Gen. surg] neoplasm (tumor) from SIMS Lahore
[Gen. surg] neoplasm (tumor) from SIMS Lahore[Gen. surg] neoplasm (tumor) from SIMS Lahore
[Gen. surg] neoplasm (tumor) from SIMS Lahore
 
Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)Basics of Immunohistochemistry (IHC)
Basics of Immunohistochemistry (IHC)
 
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACFINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
 

Similar to Neoplasm icd 10 guideline

Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Eneutron
 
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptx
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptxChp no 3 ANTI-NEOPLASTIC DRUGS.pptx
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptxMahnoorFatima92
 
Surgical oncology ( malignancies )
Surgical oncology  ( malignancies )Surgical oncology  ( malignancies )
Surgical oncology ( malignancies )Hristo Rahman
 
10 th lecture cancer.pdf
10 th lecture cancer.pdf10 th lecture cancer.pdf
10 th lecture cancer.pdfAhmedSamaha20
 
CANCER AND TYPES AND STAGES.pptx
CANCER AND TYPES AND STAGES.pptxCANCER AND TYPES AND STAGES.pptx
CANCER AND TYPES AND STAGES.pptxPratibhaSingh810125
 
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdfOghenemesaOnobiokor
 
Cancer biology b7 4 lecures
Cancer biology b7 4 lecuresCancer biology b7 4 lecures
Cancer biology b7 4 lecuresCooper Man
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugsHoda Azmy
 
Neoplasm Research Paper
Neoplasm Research PaperNeoplasm Research Paper
Neoplasm Research PaperBeth Evans
 
anticancer drugs and agents
anticancer drugs and agentsanticancer drugs and agents
anticancer drugs and agentsSagar Savale
 
Dr Patrick Treacy treating Cutaneous Malignant Melanoma
Dr Patrick Treacy treating Cutaneous Malignant MelanomaDr Patrick Treacy treating Cutaneous Malignant Melanoma
Dr Patrick Treacy treating Cutaneous Malignant MelanomaDr. Patrick J. Treacy
 
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma Dr. Patrick J. Treacy
 
Classification of Cancers by Inusah D. Iddrisu
Classification of Cancers by Inusah D. IddrisuClassification of Cancers by Inusah D. Iddrisu
Classification of Cancers by Inusah D. IddrisuINUSAH DEUNAA IDDRISU
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide shareTaniya M S
 

Similar to Neoplasm icd 10 guideline (20)

Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
 
oncology
oncologyoncology
oncology
 
Cancer
Cancer Cancer
Cancer
 
Tumour/cancer
Tumour/cancerTumour/cancer
Tumour/cancer
 
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptx
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptxChp no 3 ANTI-NEOPLASTIC DRUGS.pptx
Chp no 3 ANTI-NEOPLASTIC DRUGS.pptx
 
Surgical oncology ( malignancies )
Surgical oncology  ( malignancies )Surgical oncology  ( malignancies )
Surgical oncology ( malignancies )
 
10 th lecture cancer.pdf
10 th lecture cancer.pdf10 th lecture cancer.pdf
10 th lecture cancer.pdf
 
CANCER AND TYPES AND STAGES.pptx
CANCER AND TYPES AND STAGES.pptxCANCER AND TYPES AND STAGES.pptx
CANCER AND TYPES AND STAGES.pptx
 
clinical aspects of neoplasia
clinical aspects of neoplasiaclinical aspects of neoplasia
clinical aspects of neoplasia
 
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
 
Treatment for cancer
Treatment for cancerTreatment for cancer
Treatment for cancer
 
Cancer biology b7 4 lecures
Cancer biology b7 4 lecuresCancer biology b7 4 lecures
Cancer biology b7 4 lecures
 
Anticancer drugs
Anticancer drugsAnticancer drugs
Anticancer drugs
 
Neoplasm Research Paper
Neoplasm Research PaperNeoplasm Research Paper
Neoplasm Research Paper
 
anticancer drugs and agents
anticancer drugs and agentsanticancer drugs and agents
anticancer drugs and agents
 
Dr Patrick Treacy treating Cutaneous Malignant Melanoma
Dr Patrick Treacy treating Cutaneous Malignant MelanomaDr Patrick Treacy treating Cutaneous Malignant Melanoma
Dr Patrick Treacy treating Cutaneous Malignant Melanoma
 
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
 
Classification of Cancers by Inusah D. Iddrisu
Classification of Cancers by Inusah D. IddrisuClassification of Cancers by Inusah D. Iddrisu
Classification of Cancers by Inusah D. Iddrisu
 
Oncology
OncologyOncology
Oncology
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide share
 

Recently uploaded

Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxMUKESH PADMANABHAN
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
PeerPreneur Hour from March 14, 2023 recording
PeerPreneur Hour from March 14, 2023 recordingPeerPreneur Hour from March 14, 2023 recording
PeerPreneur Hour from March 14, 2023 recordingmlicam615
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYRMC
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxEMADABATHINI PRABHU TEJA
 
Keeping Your Bones Healthy – A Comprehensive Guide.
Keeping Your Bones Healthy – A Comprehensive Guide.Keeping Your Bones Healthy – A Comprehensive Guide.
Keeping Your Bones Healthy – A Comprehensive Guide.Gokuldas Hospital
 
Lecture (4) Anatomy of Lung & Pleura.pdf
Lecture (4) Anatomy of Lung & Pleura.pdfLecture (4) Anatomy of Lung & Pleura.pdf
Lecture (4) Anatomy of Lung & Pleura.pdfAmanuelIbrahim
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxHanineHassan2
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....sharyurangari111
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdfDolisha Warbi
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxsandhulove46637
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborHealth Catalyst
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
Effective Tips to Prevent Joint Pain -Common Causes of Joint Pain
Effective Tips to Prevent Joint Pain -Common Causes of Joint PainEffective Tips to Prevent Joint Pain -Common Causes of Joint Pain
Effective Tips to Prevent Joint Pain -Common Causes of Joint PainGokuldas Hospital
 
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTS
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTSNERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTS
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTSWINCY THIRUMURUGAN
 

Recently uploaded (20)

Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
Painting Rats White Angers Them to No End
Painting Rats White Angers Them to No EndPainting Rats White Angers Them to No End
Painting Rats White Angers Them to No End
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptx
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
PeerPreneur Hour from March 14, 2023 recording
PeerPreneur Hour from March 14, 2023 recordingPeerPreneur Hour from March 14, 2023 recording
PeerPreneur Hour from March 14, 2023 recording
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptx
 
Keeping Your Bones Healthy – A Comprehensive Guide.
Keeping Your Bones Healthy – A Comprehensive Guide.Keeping Your Bones Healthy – A Comprehensive Guide.
Keeping Your Bones Healthy – A Comprehensive Guide.
 
Lecture (4) Anatomy of Lung & Pleura.pdf
Lecture (4) Anatomy of Lung & Pleura.pdfLecture (4) Anatomy of Lung & Pleura.pdf
Lecture (4) Anatomy of Lung & Pleura.pdf
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptx
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and Labor
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
Effective Tips to Prevent Joint Pain -Common Causes of Joint Pain
Effective Tips to Prevent Joint Pain -Common Causes of Joint PainEffective Tips to Prevent Joint Pain -Common Causes of Joint Pain
Effective Tips to Prevent Joint Pain -Common Causes of Joint Pain
 
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTS
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTSNERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTS
NERVE CELLS FINAL( NEURON AND GLIAL CELLS.pptx FOR NURSING STUDENTS
 
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
 

Neoplasm icd 10 guideline

  • 1. Neoplasm ● The term neoplasm refers to an abnormal growth of tissue caused by the rapid division of cells that have undergone some form of mutation. ● Greek words "neo" meaning new and "plasma" meaning formation. ● Tumor: a swelling of a part of the body, generally without inflammation, caused by an abnormal growth of tissue, whether benign or malignant.
  • 7. Types of Neoplasm WHO classifies neoplasms into four main groups: 1. Benign neoplasm: Benign (non-cancerous) tumor is a mass of cells (tumor) that lacks the ability to invade neighboring tissue or metastasize. They are circumscribed and localized and do not transform into cancer. These neoplasms do not become cancerous and are not usually life threatening, but depending on its location, a benign growth may cause symptoms and signs if it presses on vital neighboring structures such as glands or nerves. E.g. Adenomas - Adenoma is a benign tumor of glandular tissue, such as the mucosa of stomach, small intestine, and colon, in which tumor cells form glands or gland like structures. Skin moles - Moles occur when cells in the skin grow in a cluster instead of being spread throughout the skin. Fibromas - These are growths that arise in the connective or fibrous tissue. Hemangiomas - A birthmark often appearing as a rubbery, bright red nodule of extra blood vessels. Lipomas - A fatty lump most often situated between the skin and underlying muscle layer. Osteoma, Papilloma, Meningioma, Lymphangioma, Chondroma, Astrocytoma etc.
  • 9. 2. Malignant neoplasms (Cancer) They invade and destroy the surrounding tissue, may form metastases and, if untreated or unresponsive to treatment, will prove fatal. e.g. Carcinoma - This cancer begins in the skin or tissues that line internal organs. Leukemia - This form affects tissues that make blood, such as the bone marrow. Large numbers of abnormal cells are produced in the bone marrow which then enter the bloodstream. Lymphoma - This refers to cancer that originates in the immune system. - Hodgkin's lymphoma and non-Hodgkin's lymphoma Sarcoma - This develops in bone fat, muscle, blood vessels, cartilage, bone or other types of connective tissue. Cancer of the central nervous system - This form of cancer originates in the tissues of the spinal cord and brain. Melanoma – Skin cancer Cancers related to Bladder, Breast, Brain, Liver, Cervical, Colorectal, Kidney, Lung, Ovarian, Pancreatic, Prostate, Thyroid, Uterine Cancers
  • 12. 3. Malignant neoplasm Secondary: Refers to any of a class of cancerous tumor that is either a metastatic offshoot of a primary tumor, or an apparently unrelated tumor that increases in frequency following certain cancer treatments such as chemotherapy or radiotherapy 4. Cancer in situ (In the original place): An early stage cancer in which the cancerous growth or tumor is still confined to the site from which it started, and has not spread to surrounding tissue or other organs in the body. They are localised, do not invade and destroy but in time, may transform into a cancer.
  • 13. 5. Uncertain behavior: The term "neoplasm of uncertain behavior" is a specific pathologic diagnosis. This is a lesion whose behavior cannot be predicted. It's currently benign, but there's a chance that it could undergo malignant transformation over time. Lesion - a region in an organ or tissue which has suffered damage through injury or disease, such as a wound, ulcer, abscess, or tumour. Lesion
  • 14. What Causes Cancer  Genetics  Tobacco  Diet and Physical Activity Being overweight or obese  Alcohol : Mouth, throat, voice box, esophagus, Liver, Colon, Breast.  Sun and UV Exposure  Radiation Exposure: X-rays, Gamma Rays, Radon, Second cancer caused by cancer treatment, Microwaves, Radio Waves, and Other Types of Radiofrequency Radiation, Cellular phones, Mobile towers, Electrical devices, Power lines.  Other Carcinogens : lead, arsenic, cosmetics, hair dyes, asbestos, benzene, or formaldehyde, pollution,
  • 15. Types of Treatment There are many types of cancer treatment. The types of treatment that you receive will depend on the type of cancer you have and how advanced it is. The main types of cancer treatment include: 1. Surgery Surgery is a procedure in which a surgeon removes cancer from your body. 2. Radiation Therapy Radiation therapy (also called radiotherapy) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. At low doses, radiation is used in x-rays to see inside your body, as with x- rays of your teeth or broken bones.
  • 16. 3. Chemotherapy Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to kill cancer cells. They are one of the most toxic drugs used in therapy. Side effects: Immunosuppression, Typhlitis, Gastrointestinal distress, Anemia, Fatigue, Nausea and vomiting, Hair loss, Secondary neoplasm, Infertility, Teratogenicity, Peripheral neuropathy, Cognitive impairment, Tumor lysis syndrome, Organ damage, Other side-effects.
  • 20. 4. Immunotherapy Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. It is made up of white blood cells and organs and tissues of the lymph system. e.g. Monoclonal antibodies, Cytokines, Vaccines, BCG (Bacillus Calmette-Guérin) 5. Targeted Therapy 6. Hormone Therapy 7. Stem Cell Transplant 8. Precision Medicine
  • 21. ICD-10-CM Official Guidelines for Coding and Reporting FY 2017
  • 22. General guidelines • Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. • To properly code a neoplasm it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behaviour. If malignant, any secondary (metastatic) sites should also be determined. Chapter 2: Neoplasms (C00-D49)
  • 23. • The neoplasm table in the Alphabetic Index should be referenced first. • However, if the histological term is documented, that term should be referenced first, rather than going immediately to the Neoplasm Table, in order to determine which column in the Neoplasm Table is appropriate. • For example, if the documentation indicates “adenoma,” refer to the term in the Alphabetic Index to review the entries under this term and the instructional note to “see also neoplasm, by site, benign.” • The table provides the proper code based on the type of neoplasm and the site.
  • 24.  Primary malignant neoplasms overlapping site boundaries • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code -.8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. E.g. C00.8 - Malignant neoplasm of overlapping sites of lip. C10.8 - Malignant neoplasm of overlapping sites of oropharynx • For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • 25.  Malignant neoplasm of ectopic tissue (In an abnormal place or position): Malignant neoplasms of ectopic tissue are to be coded to the site of origin mentioned, e.g., ectopic pancreatic malignant neoplasms involving the stomach are coded to pancreas, unspecified (C25.9).
  • 26. a) Treatment directed at the malignancy If the treatment is directed at the malignancy, designate the malignancy as the principal diagnosis. The only exception to this guideline is if a patient admission/encounter is solely for the administration of chemotherapy, immunotherapy or radiation therapy, assign the appropriate Z51.-- code as the first-listed or principal diagnosis, and the diagnosis or problem for which the service is being performed as a secondary diagnosis.
  • 27. b. Treatment of secondary site When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only, the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present.
  • 28. C) Coding and sequencing of complications 1. Anemia associated with malignancy Principal Dx will be malignancy followed by anemia code (i.e. D63.0, Anemia in neoplastic Disease). 2. Anemia associated with chemotherapy and immunotherapy Principal Dx will be anemia code followed by the appropriate codes for the neoplasm and the adverse effect (T45.1X5, Adverse effect of antineoplastic and immunosuppressive drugs). 3. Anemia associated with radiation therapy Principal Dx will be anemia code followed by the appropriate neoplasm code and code Y84.2, Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure. 4. Management of dehydration due to the malignancy If dehydration is being treated (intravenous rehydration), the dehydration is sequenced first, followed by the code(s) for the malignancy. 5. Treatment of a complication resulting from a surgical procedure Complication as the principal or first-listed diagnosis if treatment is directed at resolving the complication.
  • 29. d) Primary malignancy previously excised When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code. e) Admissions/Encounters involving chemotherapy, immunotherapy and radiation therapy 1. Episode of care involves surgical removal of neoplasm When an episode of care involves the surgical removal of a neoplasm, primary or secondary site, followed by adjunct chemotherapy or radiation treatment during the same episode of care, the code for the neoplasm should be assigned as principal or first-listed diagnosis.
  • 30. 2. Patient admission/encounter solely for administration of chemotherapy, immunotherapy and radiation therapy Assign the appropriate Z51.-- code as the first-listed or principal diagnosis, If a patient receives more than one of these therapies during the same admission more than one of these codes may be assigned, in any sequence. The malignancy for which the therapy is being administered should be assigned as a secondary diagnosis. 3. Patient admitted for radiation therapy, chemotherapy or immunotherapy and develops complications Assign the appropriate Z51.-- code as the first-listed or principal diagnosis, followed by any codes for the complications such as uncontrolled nausea and vomiting or dehydration.
  • 31. f. Admission/encounter to determine extent of malignancy When the reason for admission/encounter is to determine the extent of the malignancy, or for a procedure such as paracentesis or thoracentesis, the primary malignancy or appropriate metastatic site is designated as the principal or first-listed diagnosis, even though chemotherapy or radiotherapy is administered. g. Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms Symptoms, signs, and ill-defined conditions listed in Chapter 18 characteristic of, or associated with, an existing primary or secondary site malignancy cannot be used to replace the malignancy as principal or first-listed diagnosis, regardless of the number of admissions or encounters for treatment and care of the neoplasm.
  • 32. h. Admission/encounter for pain control/management See Section I.C.6. for information on coding admission/encounter for pain control/management. Neoplasm Related Pain Code G89.3 is assigned to pain documented as being related, associated or due to cancer, primary or secondary malignancy, or tumor. This code is assigned regardless of whether the pain is acute or chronic. This code may be assigned as the principal or first-listed code when the stated reason for the admission/encounter is documented as pain control/pain management. The underlying neoplasm should be reported as an additional diagnosis. When the reason for the admission/encounter is management of the neoplasm and the pain associated with the neoplasm is also documented, code G89.3 may be assigned as an additional diagnosis. It is not necessary to assign an additional code for the site of the pain.
  • 33. i. Malignancy in two or more noncontiguous sites A patient may have more than one malignant tumor in the same organ. These tumors may represent different primaries or metastatic disease, depending on the site. If the documentation be unclear, then the provider should be queried as to the status of each tumor so that the correct codes can be assigned. j. Disseminated malignant neoplasm, unspecified (spread throughout an organ or the body) Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites. k. Malignant neoplasm without specification of site Code C80.1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.
  • 34. l. Sequencing of neoplasm codes 1) Encounter for treatment of primary malignancy If the reason for the encounter is for treatment of a primary malignancy, assign the malignancy as the principal/first-listed diagnosis. The primary site is to be sequenced first, followed by any metastatic sites. 2) Encounter for treatment of secondary malignancy When an encounter is for a primary malignancy with metastasis and treatment is directed toward the metastatic (secondary) site(s) only, the metastatic site(s) is designated as the principal/first-listed diagnosis. The primary malignancy is coded as an additional code. 3) Malignant neoplasm in a pregnant patient When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1-, Malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm.
  • 35. 4) Encounter for complication associated with a neoplasm When an encounter is for management of a complication associated with a neoplasm, such as dehydration, and the treatment is only for the complication, the complication is coded first, followed by the appropriate code(s) for the neoplasm. The exception to this guideline is anemia. When the admission/encounter is for management of an anemia associated with the malignancy, and the treatment is only for anemia, the appropriate code for the malignancy is sequenced as the principal or first-listed diagnosis followed by code D63.0, Anemia in neoplastic disease. 5) Complication from surgical procedure for treatment of a neoplasm When an encounter is for treatment of a complication resulting from a surgical procedure performed for the treatment of the neoplasm, designate the complication as the principal/first-listed diagnosis. See guideline regarding the coding of a current malignancy versus personal history to determine if the code for the neoplasm should also be assigned.
  • 36. 6) Pathologic fracture due to a neoplasm When an encounter is for a pathological fracture due to a neoplasm, and the focus of treatment is the fracture, a code from subcategory M84.5, Pathological fracture in neoplastic disease, should be sequenced first, followed by the code for the neoplasm. If the focus of treatment is the neoplasm with an associated pathological fracture, the neoplasm code should be sequenced first, followed by a code from M84.5 for the pathological fracture.
  • 37. m. Current malignancy versus personal history of malignancy When a primary malignancy has been excised but further treatment, such as an additional surgery for the malignancy, radiation therapy or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is completed. When a primary malignancy has been previously excised or eradicated from its site, there is no further treatment (of the malignancy) directed to that site, and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. • Z80 Family history of primary malignant neoplasm • Z85 Personal history of malignant neoplasm
  • 38. n. Leukemia, Multiple Myeloma, and Malignant Plasma Cell Neoplasms in remission versus personal history The categories for leukemia, and category C90, Multiple myeloma and malignant plasma cell neoplasms, have codes indicating whether or not the leukemia has achieved remission. There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried. o. Aftercare following surgery for neoplasm Z51.-- Encounter for other aftercare and medical care
  • 39. p. Follow-up care for completed treatment of a malignancy Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm. The follow-up codes are used to explain continuing surveillance following completed treatment of a disease, condition, or injury. They imply that the condition has been fully treated and no longer exists. They should not be confused with aftercare codes, or injury codes with a 7th character for subsequent encounter, that explain ongoing care of a healing condition or its sequelae. Follow-up codes may be used in conjunction with history codes to provide the full picture of the healed condition and its treatment. The follow-up code is sequenced first, followed by the history code. A follow-up code may be used to explain multiple visits. Should a condition be found to have recurred on the follow-up visit, then the diagnosis code for the condition should be assigned in place of the follow-up code.
  • 40. q. Prophylactic organ removal for prevention of malignancy Prophylactic Organ Removal For encounters specifically for prophylactic removal of an organ (such as prophylactic removal of breasts due to a genetic susceptibility to cancer or a family history of cancer), the principal or first-listed code should be a code from category Z40, Encounter for prophylactic surgery, followed by the appropriate codes to identify the associated risk factor (such as genetic susceptibility or family history). If the patient has a malignancy of one site and is having prophylactic removal at another site to prevent either a new primary malignancy or metastatic disease, a code for the malignancy should also be assigned in addition to a code from subcategory Z40.0, Encounter for prophylactic surgery for risk factors related to malignant neoplasms. A Z40.0 code should not be assigned if the patient is having organ removal for treatment of a malignancy, such as the removal of the testes for the treatment of prostate cancer.
  • 41. r. Malignant neoplasm associated with transplanted organ A malignant neoplasm of a transplanted organ should be coded as a transplant complication. Assign first the appropriate code from category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use and additional code for the specific malignancy.
  • 42. CODING EXAMPLES FOR NEOPLASM 1. A 50 years old female was diagnosed with left breast carcinoma four years ago, at that time she had a left mastectomy performed with chemotherapy administration. She has been well since that time with no further treatment; except for yearly checkups. The patient is now being seen with visual disturbances, dizziness, headaches and blurred vision. Workup was completed which confirmed metastasis to the brain, accounting for these symptoms. This was identified as being metastatic from the breast, not a new primary. What will be the diagnosis codes ?
  • 43. Answer: C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary site Z85.3 - History, personal (of), malignant neoplasm (of), breast Z90.12 - Absence (of) (organ or part) (complete or partial), breast(s) (and nipple(s)) (acquired) Z92.21 - History, personal (of)chemotherapy for neoplastic condition
  • 44. 2. The diagnosis for a 61 years old female patient is small cell carcinoma of the right lower lobe of the lung with metastasis to the intrathoracic lymph nodes, brain and right rib. What will be the diagnosis codes ?
  • 45. Answer: C34.31 – Carcinoma, see also Neoplasm, by site, malignant. Refer to Neoplasm Table, by site (lung), malignant, primary site, lower lobe C77.1 - Refer to Neoplasm Table, by site, lymph gland, malignant, intrathoracic, secondary site C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary site C79.51 - Refer to Neoplasm Table, by site, bone, malignant, rib, secondary site
  • 46. 3. The encounter is to receive chemotherapy following the recent diagnosis of carcinoma of the small intestines. The tumor was in the area where the duodenum and jejunum join. The cancer was resected two months ago and the patient has been receiving chemotherapy. What will be the diagnosis codes ?
  • 47. Answer: Z51.11 - Chemotherapy (session) (for), cancer C17.8 – Carcinoma, see also Neoplasm, by site, malignant. Refer to Neoplasm Table, by site, intestine, small,overlapping lesion, malignant, primary site Z90.49 - Absence (of) (organ or part) (complete or partial), intestine (acquired) (small)
  • 48. 4. Female patient with terminal carcinoma of the central portion of the right breast, metastatic to the liver and brain, was seen for dehydration and chronic intractable neoplasm related pain. Patient was rehydrated with IVs and given IV pain medication with no treatment directed toward the cancer. What will be the diagnosis codes ?
  • 49. Answer: E86.0 - Dehydration G89.3 – Pain(s) (see also Painful), chronic, neoplasm related C50.111 – Carcinoma, see also Neoplasm, by site, malignant. Refer to Neoplasm Table, by site (breast), malignant, primary site, central portion C79.31 - Refer to Neoplasm Table, by site, brain, malignant, secondary site C78.7 - Refer to Neoplasm Table, by site, liver, malignant, secondary site
  • 50. 5. A 25 years old female is treated for melanoma of the breast and left arm. What will be the diagnosis codes ?
  • 51. Answer: C43.52 - Melanoma (malignant), skin, breast (female) (male) C43.62 - Melanoma (malignant), skin, arm. Review the Tabular for complete code assignment.